Formal total synthesis of spirangien A

Area of Science:

• Organic Chemistry
• Natural Product Synthesis
• Medicinal Chemistry

Background:

• Spirangien A is a cytotoxic metabolite produced by myxobacteria.
• Its complex spiroketal structure presents a significant synthetic challenge.
• Understanding its synthesis can aid in developing new therapeutic agents.

Purpose of the Study:

• To achieve the first formal total synthesis of the cytotoxic myxobacteria metabolite spirangien A.
• To develop a synthetic strategy that mirrors the proposed biosynthesis of spirangien A.
• To establish key reactions for constructing the spiroketal core and introducing critical functional groups.

Main Methods:

• Utilized a late-stage introduction of the C20 alcohol, mimicking biosynthesis.
• Employed a high-yielding cross metathesis reaction between an enone and an alkene.
• Applied a manganese-catalyzed conjugate reduction α-oxidation for hydroxyl group installation.

Main Results:

• Successfully synthesized an advanced intermediate of spirangien A.
• The cross metathesis yielded the desired E-enone intermediate efficiently.
• The α-oxidation successfully introduced the C20 hydroxyl group.
• Acid treatment of the α-hydroxyketone afforded the spiroketal core.

Conclusions:

• The described synthetic route provides a viable pathway to spirangien A.
• The strategy highlights the utility of late-stage functionalization in complex molecule synthesis.
• This work contributes to the broader understanding of myxobacterial natural product synthesis and potential drug discovery.